Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.1632

Is gestational diabetes a risk for diabetic retinopathy? Insights from Big Data

Part of Topic

Maternal medicine

Audio

Introduction

Gestational diabetes (GDM) affects 4-5% of pregnancies yearly

- associated with a variety of long-term cardiovascular complications

- association with diabetic retinopathy (DR) not well-described in the literature

A pilot study (manuscript submitted) showed that women with GDM had a significant increase in their risk for DR over 10 years vs. women without diabetes.

 

AIMS

To assess whether a background in GDM augments the risk of long-term DR in a cohort of women with incident diabetes

 

METHODS

Cohort definition

-Records of women >18 yo with a coding for DM or an antidiabetic prescription between 2007-2013 extracted from CPRD Aurum.
-Algorithm developed to define the point  at which INCIDENT diabetes was diagnosed, taking into account the first of the following three pieces of evidence

1)A first observation indicative for diabetes in the primary or secondary care record

2)A first prescription of an anti-diabetic medication

3)A first glycaemic test reaching a diagnostic threshold for diabetes

-Subjects whose diabetes was diagnosed outside the 2007-2013 window were excluded.
-Further refinements were needed to disambiguate DM from GDM where the coding was equivocal (e.g.; ‘diabetes in pregnancy’ or when a subject’s evidence for diabetes came from a prescription for metformin or insulin or a diagnostic glycaemic test, which could also be suggestive of GDM), and also from PCOS (see Fig. 1 & 2).
-Once timepoint of diagnosis of diabetes had been defined, only subjects for whom it fell between 2007-2013 were included.  Those with a diagnosis of GDM more than 1 year prior to that date (to account for incidental DM found in pregnancy and misdiagnosed as GDM) were entered into the GDM group and the others were entered in the NON-GDM group.

 Statistical analysis

Demographic characteristics of the two groups are presented in the Table in the Results.

As the aim of the project was to demonstrate that GDM could be a useful flag for a later increased risk of DR rather than to explore causality, time-to-event analysis did not have to be adjusted for co-variates. Therefore, univariable analysis was performed using Kaplan-Meier (KM) survival analysis and the log-rank test. A p value of <0.05 was used to define statistical significance.  All analysis was performed in R (latest version).

RESULTS

The description of the cohort in terms of group sizes and demographics are shown above.

 Below, time-to-DR survival curves are demonstrated in Fig 4.

 Discussion - demographics

1) GDM group more ethnically mixed (as expected given screening criteria).

 2) GDM group on average 10 years younger at the point of diabetes diagnosis, perhaps due ot screening for diabetes in this group, but group sizes are very different so hard to interpret.

 3) High rate of obesity in both groups (mean BMI  37.8 vs. 32.4 in non-GDM vs. GDM

CONCLUSION

KM curve clearly demonstrates long-term increased risk in DR amongst women with a background of GDM. 

Multivariable analysis to follow.

Clinical studies investigating development of DR from the point at which GDM is diagnosed onwards are now required to demonstrate this effect in practice.

Should this effect be demonstrated, women should start screening for DR after GDM, even before formal diagnosis of DM.

With new attachments to smartphones which provide retinal images, the ability to undertake screening for DR at home in the future (and DM by extension), screening could be rendered more practical for patients. This would improve screening uptake and earlier diagnosis..

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.